GeneSys Bio
GeneSys Bio is a biomedical startup dedicated to providing rapid, sensitive, and specific pathogen detection technologies. With a mission to make advanced molecular diagnostics accessible everywhere, the company leverages innovative genetic technology and a sample-to-result platform to serve clinicians and patients. Their solutions aim to deliver results in less than an hour, with high accuracy, ease of use, portability, and economic efficiency, focusing initially on urinary tract infections and expanding to various infectious challenges in humans, animals, and the environment.
Industries
Nr. of Employees
small (1-50)
GeneSys Bio
Products
Sample-to-result PCR-based diagnostic platform for rapid pathogen detection
Integrated, portable platform that automates PCR-based molecular workflows to deliver rapid, sensitive and specific pathogen detection results at point of need.
Sample-to-result PCR-based diagnostic platform for rapid pathogen detection
Integrated, portable platform that automates PCR-based molecular workflows to deliver rapid, sensitive and specific pathogen detection results at point of need.
Services
Assay and device development for rapid molecular diagnostics
Collaborative development of molecular assays and integrated diagnostic devices intended for rapid, on-site pathogen detection and monitoring.
Prototype validation and proof-of-concept services
Prototype device construction and early-stage technical validation to demonstrate feasibility and support further development or investment.
Assay and device development for rapid molecular diagnostics
Collaborative development of molecular assays and integrated diagnostic devices intended for rapid, on-site pathogen detection and monitoring.
Prototype validation and proof-of-concept services
Prototype device construction and early-stage technical validation to demonstrate feasibility and support further development or investment.
Expertise Areas
- Molecular diagnostics development
- Point-of-care device engineering
- Assay development for infectious diseases
- Antimicrobial resistance diagnostics
Key Technologies
- Polymerase chain reaction (PCR)-based diagnostics
- Sample-to-result automation
- Point-of-care portable diagnostic hardware
- AI-driven diagnostic optimization